Legal & General Group PLC Nu Cana PLC Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$0.59 - $1.06 $27,396 - $49,220	-46,434 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.02 - $2.9 $93,796 - $134,658	46,434 New	46,434 $111,000
Q2 2019 Aug 14, 2019	SELL	$9.74 - $17.45 $457 - $820	-47 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$13.0 - $22.57 $1,495 - $2,595	-115 Reduced 70.99%	47 $1,000
Q2 2018 Aug 10, 2018	BUY	$19.0 - $29.84 $3,078 - $4,834	162 New	162 $3,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $59.5M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.